Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional studies on the ATM intronic splicing processing element.

Marzena A Lewandowska1, Cristiana Stuani, Alireza Parvizpur

  • 1International Centre for Genetic Engineering and Biotechnology Padriciano 99, 34012 Trieste, Italy.

Nucleic Acids Research
|July 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood-based RNA-Seq of 5412 individuals with rare disease identifies new candidate diagnoses in the National Genomic Research Library.

medRxiv : the preprint server for health sciences·2026
Same author

AAV2-mediated intravitreal delivery of exon-specific U1 snRNA rescues optic neuropathy in familial dysautonomia.

Molecular therapy. Nucleic acids·2026
Same author

Optineurin Shapes Basal and LPS-Induced Transcriptomes in BV2 Microglia.

International journal of molecular sciences·2025
Same author

AAV2-mediated intravitreal delivery of exon-specific U1 snRNA rescues optic neuropathy in a mouse model of familial dysautonomia.

bioRxiv : the preprint server for biology·2025
Same author

hnRNP A1 induces aberrant <i>CFTR</i> exon 9 splicing via a newly discovered ESS element.

Life science alliance·2025
Same author

Characterization and Engineered U1 snRNA Rescue of Splicing Variants in a Turkish Neurodevelopmental Disease Cohort.

Human mutation·2025
Same journal

Neurochondrin promotes U5 snRNP maturation by regulating AAR2 release from PRPF8.

Nucleic acids research·2026
Same journal

Elongationless start-stop elements are stress-resilient translation gates that are more repressive than uTranslons.

Nucleic acids research·2026
Same journal

Evolution of the ribosomal exit tunnel through the eyes of the nascent chain.

Nucleic acids research·2026
Same journal

Enhancing the performance and interpretability of epigenetic clocks.

Nucleic acids research·2026
Same journal

FABIAN-variant 2026: improved prediction of the effects of DNA variants on transcription factor binding.

Nucleic acids research·2026
Same journal

Structural and biochemical characterization of Grimontia hollisae thermostable direct hemolysin with DNA reveals first Vibrio hemolysin with nuclease activity.

Nucleic acids research·2026
See all related articles

Deep intronic variants can cause disease by activating aberrant exons. U1 snRNP binding downstream of intronic splicing processing elements (ISPEs) prevents this aberrant splicing, offering a potential therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Genetics
  • RNA Splicing

Background:

  • Deep intronic variants in disease-associated genes pose challenges for functional understanding.
  • A novel disease mechanism involves intronic splicing processing elements (ISPEs) with adjacent splice sites.
  • A specific deletion in ATM's ISPE disrupts U1 snRNP interaction, activating an aberrant exon.

Purpose of the Study:

  • To investigate the mechanism by which U1 snRNP binding prevents aberrant splicing.
  • To explore the role of U1 snRNP interaction downstream of ISPEs.
  • To evaluate the therapeutic potential of modulating U1 snRNP binding for aberrant splicing.

Main Methods:

  • Selective mutagenesis of ISPE splice sites.
  • Functional comparison of ATM mouse counterparts.

Related Experiment Videos

  • Analysis of pre-mRNA splicing intermediates using cell lines and minigene assays.

    • Main Results:

    • U1 snRNA binding downstream of ISPEs prevents aberrant exon activation.
    • This U1 snRNP binding interferes with cryptic acceptor site usage.
    • Mutagenesis confirmed the effect is not due to ISPE resplicing.
    • Artificial U1 snRNA binding can prevent aberrant splicing of a CFTR cryptic exon.

    Conclusions:

    • U1 snRNP binding to intronic sequences downstream of ISPEs is crucial for correct intron processing.
    • ISPE-like elements binding U1 snRNPs may act as regulators of splicing.
    • Modulating U1 snRNP interactions offers a potential therapeutic avenue for diseases caused by aberrant splicing.